ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,248.49
-0.86%
Dow Jones
41,938.45
-1.63%
Gold vs US Dollar
2,690.06
0.74%
Brent Oil
79.285
3.07%
Bitcoin
94,785.86
2.57%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Qualigen Therapeutics Inc (QLGN)

  7. Qualigen Therapeutics Inc (QLGN) News

Qualigen Therapeutics (QLGN)

Qualigen Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:QLGN
DateTimeSourceHeadlineSymbolCompany
26/12/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
20/12/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:QLGNQualigen Therapeutics Inc
10/12/202419:27Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:QLGNQualigen Therapeutics Inc
05/12/202414:00GlobeNewswire Inc.Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity RequirementNASDAQ:QLGNQualigen Therapeutics Inc
25/11/202422:00GlobeNewswire Inc.Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)NASDAQ:QLGNQualigen Therapeutics Inc
22/11/202422:28Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:QLGNQualigen Therapeutics Inc
21/11/202422:10Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:QLGNQualigen Therapeutics Inc
21/11/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
19/11/202414:00GlobeNewswire Inc.Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred SharesNASDAQ:QLGNQualigen Therapeutics Inc
15/11/202421:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:QLGNQualigen Therapeutics Inc
14/11/202421:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QLGNQualigen Therapeutics Inc
13/11/202422:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
08/11/202422:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
01/11/202420:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
01/11/202413:00GlobeNewswire Inc.Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024NASDAQ:QLGNQualigen Therapeutics Inc
29/10/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
24/10/202421:06Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:QLGNQualigen Therapeutics Inc
22/10/202420:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
17/10/202420:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:QLGNQualigen Therapeutics Inc
09/10/202420:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
09/10/202420:10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:QLGNQualigen Therapeutics Inc
26/09/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
26/09/202421:10GlobeNewswire Inc.Qualigen Therapeutics, Inc. Announces management changes.NASDAQ:QLGNQualigen Therapeutics Inc
20/09/202420:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
20/09/202413:00GlobeNewswire Inc.Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings PanelNASDAQ:QLGNQualigen Therapeutics Inc
09/09/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
06/09/202421:00GlobeNewswire Inc.Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. (NASDAQ: QLGN)NASDAQ:QLGNQualigen Therapeutics Inc
06/09/202420:30GlobeNewswire Inc.Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public OfferingNASDAQ:QLGNQualigen Therapeutics Inc
06/09/202419:46Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:QLGNQualigen Therapeutics Inc
05/09/202413:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QLGNQualigen Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:QLGN

Your Recent History

LSE
VAST
Vast Resources
LSE
SYME
Supply@me Capital
LSE
AAZ
Anglo Asian Mining
LSE
TRP
Tower Resources
LSE
SCLP
Scancell
LSE
IMM
Immupharma
LSE
MIN
Minoan
LSE
GEX
Georgina Energy
LSE
TERN
Tern
LSE
JLP
Jubilee Metals
LSE
NFDS
Northern Foods
LSE
TW.
Taylor Wimpey
LSE
GLEN
Glencore
LSE
VCP
Victoria
LSE
POS
Plexus
LSE
LLOY
Lloyds Banking
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads